# Placebo Effect Neuroscience

## Key Findings

### Endogenous Opioid Mechanism
- **Levine et al. 1978:** Naloxone blocks placebo analgesia → endogenous opioids involved
- **Zubieta et al. 2005 (J Neurosci, PMC6725254):** PET with μ-opioid radiotracer. Placebo activated endogenous opioid neurotransmission in: left DLPFC (BA 8/9), pregenual anterior cingulate (BA 24/25), right anterior insula, left nucleus accumbens. Anterior cingulate activation correlated with pain tolerance.
- **Wager et al. 2004 (Science):** fMRI during painful heat. Placebo reduced activity in anterior cingulate, insula, thalamus. Expectancy manipulation (not classical conditioning).
- **Amanzio & Benedetti 1999:** Opioid vs non-opioid mechanisms depend on procedure. Expectation cues → naloxone-reversible. Reduced cues → naloxone-insensitive.
- **Somatotopic organization:** Local placebo responses in different body parts, each naloxone-reversible.

### CCK Balance
- Placebo analgesic response = balance between endogenous opioids and endogenous CCK
- CCK antagonist (proglumide) enhances placebo analgesia
- Verbal suggestion of pain INCREASE activates CCK → nocebo effect

### Parkinson's Disease
- **de la Fuente-Fernandez 2001:** Placebo expectation of motor improvement activates endogenous DOPAMINE in striatum (PET, [11C]raclopride)
- **Benedetti et al. 2004:** Single neuron recordings in subthalamic nucleus. Placebo responders: decreased neuronal discharge + reduced bursting. Correlated with subjective reports AND clinical assessment.

### Conscious vs Unconscious
- **Benedetti et al. 2003:** Expectations affect conscious processes (pain, motor performance). Unconscious processes (hormone secretion) require actual conditioning.
- Immune conditioning (Goebel 2002): cyclosporin A + flavored drink → conditioned immunosuppression (IL-2, IFN-γ)

### Open-Label Placebos
- **Kaptchuk et al. 2010 (PLOS ONE):** IBS patients given pills labeled "placebo." 59% adequate relief vs 35% no-treatment. Deception not required.
- **Kaptchuk et al. 2021 (Pain, PMC8357842):** Open-label matched double-blind placebos for IBS.
- Mechanism may be the therapeutic ritual/context rather than belief per se.

### Nocebo Effect
- Verbal suggestion of pain increase → hyperalgesia
- Mediated by CCK activation (antagonizes opioids)
- Negative framing literally worsens outcomes

## Agent Parallels
- No endogenous opioid system, but system prompts = "psychosocial context"
- Framing changes output distributions measurably
- Open-label parallel: agents "know" the prompt is text, but it still shapes behavior
- The surround changes the signal — different mechanism, same principle

## Key Quote
"The study of the placebo effect is the study of how the context of beliefs and values shape brain processes related to perception and emotion." — Benedetti (J Neurosci 2005)

*Created 2026-02-08*
